Uzbek Court Sentences 23 Over Child Deaths Linked to Indian Cough Syrup

In a significant legal development, a court in Uzbekistan has sentenced 23 individuals to varying prison terms following a trial concerning the deaths of 68 children. These fatalities were attributed to contaminated cough syrups produced by Marion Biotech, an Indian pharmaceutical company. The trial, which spanned six months, concluded on February 26, with sentences ranging from two to 20 years for the accused. Among those convicted is Singh Raghvendra Pratap, an executive director of Quramax Medical, who received the maximum sentence for his role in distributing substandard medication in Uzbekistan.

The case came to light after the Central Asian nation reported a death toll linked to these medicines, which later increased to 68 following further investigations by prosecutors at the Tashkent city court. The defendants were found guilty of a range of offenses, including tax evasion, selling substandard or counterfeit medicines, abuse of office, negligence, forgery, and bribery. This case also implicated former senior officials responsible for licensing imported medicines, who have now been sentenced to lengthy prison terms.

In response to the tragedy, the court has ordered compensation payments to the families of the victims. Each family of the deceased children will receive $80,000, while four children who became disabled due to the syrup’s consumption, along with the families of eight other affected children, will receive compensation ranging from $16,000 to $40,000. The compensation will be funded by seven of the convicted individuals, highlighting the court’s effort to provide some measure of relief to the affected families amidst this healthcare scandal.

Pic Courtesy: google/ images are subject to copyright